Utilizing immunohistochemical staining as a means to detect YAP1 protein expression within each group of mice models, our findings indicate a significant reduction in total YAP1 protein content following PCOS + n-3 PUFA treatment as compared with the PCOS group, as illustrated in Figure 5a. This evidence concerns the gene YAP1 and polycystic ovary syndrome.